肝动脉栓塞化疗（TACE）；
手术切除及选择性肝动脉栓塞化疗是治疗的选择。
Resection and selective embolic chemotherapy of hepatic artery are among therapeutic modalities.
手术切除及选择性肝动脉栓塞化疗是治疗的选择。
Resection and selective embolic chemotherapy of hepatic artery are among ther...
目的：探讨中药对肝动脉栓塞化疗所致肝损害的治疗效果。
Objective: To observe the effect of Chinese herbal medicine on hepatic artery chemoembolization caused liver damage.
探讨肝癌肝动脉栓塞化疗后肿瘤的病理及某些分子生物学的变化。
Objective: To observe the pathological and molecular changes of the primary liver carcinoma after chemoembolization.
目的观察爱迪注射液减轻肝动脉栓塞化疗治疗原发性肝癌的毒副作用。
Objective to observe Aidi injection in relieving side-effect caused by hepatic arterial chemoembolization in treating primary hepatocarcinoma.
目的判断肝动脉栓塞化疗术联合氩氦刀冷冻术治疗巨块型肝癌的效果。
Objective To summarize the outcomes of hepatic artery embolism chemotherapy in combination with argon-helium knife cryotherapy in treatment of patients with giant liver cancer.
结论经肝动脉栓塞化疗是治疗肝转移癌的一种有效疗法，不良反应可耐受。
ConclusionThe TACE in the treatment of the metastatic liver cancer is effective and tolerable.
目的：观察扶正解毒汤配合肝动脉栓塞化疗术(TACE)治疗原发性肝癌的治疗效果。
Objective: To observe the curative effect of Fuzheng Jiedu Decoction combined with TACE in treating primary liver cancer.
目的：研究中药96 0合剂内服配合肝动脉栓塞化疗（TACE）治疗晚期肝癌的临床疗效。
Objective: To evaluate the clinical effectiveness of herbal medication 960 mixture combined with transcatheter arterial chemoembolization (TACE) in the treatment of advanced liver cancer.
结论肝动脉栓塞化疗（TACE）联合CT导向下的氩氦刀治疗肝癌效果明显优于单纯栓塞化疗。
The therapeutic effects TACE combined with CT guided percutaneous targeted argon-helium cryoablation of liver cancer show better results than of TACE alone.
结论：肝转移癌的早期诊断是提高生存率的关键，手术切除及选择性肝动脉栓塞化疗是改善其预后的选择。
Conclusion: Early diagnosis is the key to increase survival rate. Resection and selective embolic chemotherapy of hepatic artery are among therapeutic modalities.
目的观察评价立体定向放疗-体部伽玛刀联合经肝动脉栓塞化疗（TACE）治疗原发性肝癌（PHC）的临床疗效。
Objective To evaluate the effects of stereotactic conformal radiotherapy-body gamma knife combined with transcath- eter arterial chemoembolization(TACE)for primary hepatic carcinoma(PHC).
结论积极行手术切除肿瘤是胰体尾癌肝转移患者获得长期生存的惟一途径，术中肝动脉栓塞化疗是治疗肝转移灶的重要方法。
Conclusion Radical resection is the unique method for long survival and hepatic arterial embolization chemotherapy in operation is an important way for hepatic metastasis.
目的探讨肝癌合并门静脉癌栓的手术疗效，评价术中门静脉癌栓取出术和术后辅助肝动脉栓塞化疗对提高肝癌术后生存率的影响。
Objective To explore the value of removing portal vein tumor thrombus (PVTT) and TACE in improving the outcome of resection for primary liver cancer with PVTT.
目的：比较原发性肝细胞癌经皮导管肝动脉栓塞化疗（TACE）与TACE联合CT导向下碘油乙醇注射消融（CT-LPEI）的疗效。
Objective:To compare the therapeutic effectiveness of transcatheter arterial chemoembolization (TACE) combined with CT guided percutaneous lipiodol-ethanol injection (CT-LPEI) with that of TACE alone.
目的：探讨肝恶性肿瘤经导管动脉化疗栓塞术(TACE)后出现缺血性并发症的频次、治疗方法和预后。
Purpose: To evaluate the frequency, methods of treatment, and the outcome of ischemic complications after transcatheter arterial chemoembolization (TACE) in hepatic malignant tumors.
对12例肝癌采用经肝动脉灌注化疗栓塞治疗，观察临床疗效。
Methods 12 patients with liver cancer used TACE then observed clinical efficacy.
了解预防性肝动脉化疗栓塞术（TACE）在延缓肝癌手术后复发方面的作用。
To investigate effect of postoperative prophylactic transcatheter arterial chemoembolization(TACE)on delaying recurrence in patients with hepatocellular carcinoma(HCC).
方法在切除原发病灶的同时对不能切除的肝转移癌在术中同时置入肝动脉植入式药泵并给予化疗栓塞。
Methods For inoperable combined hepatic metastasis drug delivery system (DDS) was set in liver artery and chemotherapy embolism was injected during the reoperation of primary original cancer.
积极治疗组接受胆道引流、手术和肝动脉化疗栓塞等治疗。
The cases of active treatment group received biliary tract drainage, operation and transcatheter hepatic arterial chemoembolization, et al.
结论用MSCT血管重建和肝动脉、门静脉双重化疗栓塞治疗转移性肝癌有一定临床效果，且无明显毒副作用。
CONCLUSION: Vascular restructure with MSCT and chemoembolization through portal vein and liver artery, with no obvious side-effects, are effective for patients with liver cancer metastases.
目的评价肝动脉化疗栓塞联合生物治疗对原发性肝癌的疗效。
Objective Evaluating the effect of hepatic artery embolism chemotherapy combined with biological therapy to treat primary liver cancer.
方法：49 例无手术指征肝癌患者，行单纯肝动脉栓塞与在肝动脉栓塞的基础上行肝门静脉化疗的对照研究。
Methods: 49 patients with late liver carcinoma were treated with embolism of hepatic artery and combined with chemotherapy through portal vein were reported.
目的评价经肝动脉化疗栓塞-冷循环微波刀序贯治疗对肝癌的安全性和有效性。
Objective To comment the salty and effect of combining cooled-tip electrodes and transcatheter arterial chemoembolization(TACE)for the treatment of patients with primary hepatocellular carcinoma.
本文将动脉介入与持续灌注化疗药物两种方法相结合，观察结直肠癌肝转移患者经肝动脉介入栓塞或持续灌注化疗的临床疗效。
This study was designed to evaluate the efficacy of continuous hepatic artery infusion chemotherapy and chemoembolization for the treatment of liver metastases from colorectal cancer.
结论高位胆管癌外科手术治疗是主要手段，腔内照射及肝动脉化疗栓塞，可预防或延迟局部复发及转移，延长病人生存时间。
Conclusion Surgery is the primary therapeutic method of high bile duct carcinoma, while internal radiation and TAE can prevent or delay the relapse and metastasis and prolong the survival.
结论高位胆管癌外科手术治疗是主要手段，腔内照射及肝动脉化疗栓塞，可预防或延迟局部复发及转移，延长病人生存时间。
Conclusion Surgery is the primary therapeutic method of high bile duct carcinoma, while internal radiation and TAE can prevent or delay the relapse and metastasis and prolong the survival.
应用推荐